346 related articles for article (PubMed ID: 18086519)
41. Resource utilization in home health chronic obstructive pulmonary disease management.
Steinel JA; Madigan EA
Outcomes Manag; 2003; 7(1):23-7. PubMed ID: 12593122
[TBL] [Abstract][Full Text] [Related]
42. Repeatability of health economic data in COPD.
Nielsen R; Johannessen A; Schnelle HM; Bakke PS; Askildsen JE; Omenaas ER; Gulsvik A
Respir Med; 2008 Nov; 102(11):1556-62. PubMed ID: 18674894
[TBL] [Abstract][Full Text] [Related]
43. COPD: illness severity, resource utilisation and cost.
Tynan AJ; Lane SJ
Ir Med J; 2005 Feb; 98(2):41-2, 44-5. PubMed ID: 15835510
[TBL] [Abstract][Full Text] [Related]
44. Assessing the costs of chronic obstructive pulmonary disease: the state medicaid perspective.
Marton JP; Boulanger L; Friedman M; Dixon D; Wilson J; Menzin J
Respir Med; 2006 Jun; 100(6):996-1005. PubMed ID: 16288858
[TBL] [Abstract][Full Text] [Related]
45. Comparison of outpatient visits and hospitalisations, in patients with chronic obstructive pulmonary disease, before and after influenza vaccination.
Menon B; Gurnani M; Aggarwal B
Int J Clin Pract; 2008 Apr; 62(4):593-8. PubMed ID: 18284444
[TBL] [Abstract][Full Text] [Related]
46. [Socioeconomic relevance of acute exacerbations of chronic bronchitis in the Federal Republic of Germany. A prospective cost of illness study].
Rychlik R; Pfeil T; Daniel D; Pfeil B; Mast O; Thate-Waschke I; Lorenz J
Dtsch Med Wochenschr; 2001 Mar; 126(13):353-9. PubMed ID: 11332229
[TBL] [Abstract][Full Text] [Related]
47. Comparative cost analysis of outpatient and inpatient rehabilitation for musculoskeletal diseases in Germany.
Zeidler J; Mittendorf T; Vahldiek G; Zeidler H; Merkesdal S
Rheumatology (Oxford); 2008 Oct; 47(10):1527-34. PubMed ID: 18682412
[TBL] [Abstract][Full Text] [Related]
48. Costs associated with outpatient, emergency room and inpatient care for migraine in the USA.
Insinga RP; Ng-Mak DS; Hanson ME
Cephalalgia; 2011 Nov; 31(15):1570-5. PubMed ID: 22013140
[TBL] [Abstract][Full Text] [Related]
49. The burden of prenatal exposure to alcohol: revised measurement of cost.
Stade B; Ali A; Bennett D; Campbell D; Johnston M; Lens C; Tran S; Koren G
Can J Clin Pharmacol; 2009; 16(1):e91-102. PubMed ID: 19168935
[TBL] [Abstract][Full Text] [Related]
50. Economic assessment of early initiation of inhaled corticosteroids in chronic obstructive pulmonary disease using propensity score matching.
Akazawa M; Biddle AK; Stearns SC
Clin Ther; 2008; 30 Spec No():1003-16. PubMed ID: 18640475
[TBL] [Abstract][Full Text] [Related]
51. The Economic Burden of Comorbid Obstructive Sleep Apnea Among Patients with Chronic Obstructive Pulmonary Disease.
Hong YD; Onukwugha E; Slejko JF
J Manag Care Spec Pharm; 2020 Oct; 26(10):1353-1362. PubMed ID: 32996389
[TBL] [Abstract][Full Text] [Related]
52. Costs associated with resource utilization during the palliative phase of care: a Canadian perspective.
Dumont S; Jacobs P; Fassbender K; Anderson D; Turcotte V; Harel F
Palliat Med; 2009 Dec; 23(8):708-17. PubMed ID: 19837702
[TBL] [Abstract][Full Text] [Related]
53. Can a chronic disease management pulmonary rehabilitation program for COPD reduce acute rural hospital utilization?
Rasekaba TM; Williams E; Hsu-Hage B
Chron Respir Dis; 2009; 6(3):157-63. PubMed ID: 19643830
[TBL] [Abstract][Full Text] [Related]
54. Resource use study in COPD (RUSIC): a prospective study to quantify the effects of COPD exacerbations on health care resource use among COPD patients.
FitzGerald JM; Haddon JM; Bradly-Kennedy C; Kuramoto L; Ford GT;
Can Respir J; 2007 Apr; 14(3):145-52. PubMed ID: 17464378
[TBL] [Abstract][Full Text] [Related]
55. Economic assessment of initial maintenance therapy for chronic obstructive pulmonary disease.
Akazawa M; Hayflinger DC; Stanford RH; Blanchette CM
Am J Manag Care; 2008 Jul; 14(7):438-48. PubMed ID: 18611095
[TBL] [Abstract][Full Text] [Related]
56. Direct medical costs of chronic obstructive pulmonary disease: chronic bronchitis and emphysema.
Wilson L; Devine EB; So K
Respir Med; 2000 Mar; 94(3):204-13. PubMed ID: 10783930
[TBL] [Abstract][Full Text] [Related]
57. The effect of COPD health forecasting on hospitalisation and health care utilisation in patients with mild-to-moderate COPD.
Bakerly ND; Roberts JA; Thomson AR; Dyer M
Chron Respir Dis; 2011; 8(1):5-9. PubMed ID: 21248023
[TBL] [Abstract][Full Text] [Related]
58. Acute exacerbations of COPD in the United States: inpatient burden and predictors of costs and mortality.
Perera PN; Armstrong EP; Sherrill DL; Skrepnek GH
COPD; 2012 Apr; 9(2):131-41. PubMed ID: 22409371
[TBL] [Abstract][Full Text] [Related]
59. An international observational prospective study to determine the cost of asthma exacerbations (COAX).
Lane S; Molina J; Plusa T
Respir Med; 2006 Mar; 100(3):434-50. PubMed ID: 16099149
[TBL] [Abstract][Full Text] [Related]
60. Hospitalizations for acute exacerbations of chronic obstructive pulmonary disease: how you count matters.
Stein BD; Charbeneau JT; Lee TA; Schumock GT; Lindenauer PK; Bautista A; Lauderdale DS; Naureckas ET; Krishnan JA
COPD; 2010 Jun; 7(3):164-71. PubMed ID: 20486814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
